Share Buyback in H. Lundbeck A/S


                        
Acting on its authorization to acquire up to 10% of its shares the H.
Lundbeck Supervisory Board has resolved to initiate a share buyback
program. Under the program H. Lundbeck will buy own shares for an
amount of up to DKK 6 billion until end of 2007, cf. stock exchange
announcement number 166 on 17th August 2005.

During any one single trading day a maximum of 25% of the average
daily trading volume of Lundbeck shares on the Copenhagen Stock
Exchange, calculated over 20 days prior to each trading date, will be
bought back, as the share buyback program is implemented in
accordance with the provisions of the European Commission's
regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an
announcement in respect of the transactions made under the program.

The following transactions have been made under the program:


                       No. of shares        Average Transaction value
                                     purchase price             (DKK)
                                              (DKK)
Accumulated, last         21,150,375       135.0919     2,857,244,091
announcement
25 July 2007                  21,108       140.8358         2,972,761
26 July 2007                      --             --                --
27 July 2007                      --             --                --
30 July 2007                      --             --                --
31 july 2007                      --             --                --
1 August 2007                 20,138       140.9161         2,837,767
2 August 2007                     --             --                --
Accumulated under the     21,191,621       135.1031     2,863,054,619
program




Following the above buyback it is hereby announced that Lundbeck owns
a total of 7,902,478 own shares at a nominal value of DKK 5, equal to
3.71% of the total number of 212,738,273 shares.

The content of this release will have no influence on the Lundbeck
Group's financial result for 2007.

Lundbeck contacts


Investors:                  Media:

Jacob Tolstrup              Caroline Broge
Investor Relations Manager, Media Relations Manager
North America               +45 36 43 26 38
+1 201 350 0187


                      ________________________

Stock Exchange Release No 281 - 2 August 2007

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com

Subscribe